This contract involves the supply of pharmaceutical products to the Independent Public Health Care Facility in Bochni, named after Blessed Marta Wiecka. The contract is divided into several packages, including: Package 1 - Compounded Substances, Package 2 - Ethanol, Package 3 - Infusion Fluids I, Pa
Contract awarded. Originally published 1 years ago.
Only 1 prior award here — too little to read.
In healthcare medical, INDEPENDENT PUBLIC HEALTH CARE FACILITY IN BOCHNIA COUNTY HOSPITAL NAMED AFTER BLESSED MARTA WIECKA has awarded 1 contract to 1 supplier.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the supply of medical equipment necessary for conducting endoscopic examinations at the Independent Public Healthcare Facility in Bochnia, known as the Blessed Marta Wiecka County Hospital. Suppliers are required to refer to the Detailed Price Offer Form - Technical Specificat
This contract opportunity involves the supply of medical equipment for performing endoscopic examinations at the Independent Public Healthcare Facility in Bochnia, named after Blessed Marta Wiecka. The detailed specifications and requirements for the equipment are outlined in the Detailed Price Offe
This contract involves the modernization and reconstruction of Building C, including the renovation of the Emergency Department and the Laboratory Diagnostics Center, along with the replacement of equipment. Additionally, it includes the modernization, extension, and furnishing of Pavilion C for ger
Ireland is seeking a qualified occupational health services provider to deliver comprehensive workplace health assessments, medical surveillance, and occupational health advisory services.
NHSBT seeks suppliers of colour-coded EDTA sample tubes with bar-code labels to support testing of 1.5 million annual blood and tissue donations across two English facilities.
BHRUT seeks an outsourced dermatology service provider to treat 800 waiting list patients from November 2026 to March 2027 (£520,000 contract value).
A competitive NHS framework agreement enabling the supply of unlicensed imported medicines to healthcare organisations and eligible public bodies, subject to strict regulatory compliance and quality assurance standards.
